Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease.

Autor: Xu, Chenshu1 (AUTHOR), Zou, Haoman1 (AUTHOR), Yu, Xi1 (AUTHOR), Xie, Yazhou1 (AUTHOR), Cai, Jiaxin1 (AUTHOR), Shang, Qi1 (AUTHOR), Ouyang, Na1 (AUTHOR), Wang, Yinan1 (AUTHOR), Xu, Pan1 (AUTHOR), He, Zhendan1 (AUTHOR), Wu, Haiqiang1 (AUTHOR) wuhq@szu.edu.cn
Zdroj: ChemistryOpen. Sep2021, Vol. 10 Issue 9, p877-881. 5p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje